Integrated Advisors Network’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06M Buy
24,243
+17,437
+256% +$807K 0.05% 311
2026
Q2
$290K Sell
6,806
-316
-4% -$17.2K 0.01% 580
2026
Q1
$447K Sell
7,122
-414
-5% -$33.1K 0.02% 482
2025
Q4
$719K Sell
7,536
-38
-0.5% -$3.73K 0.03% 408
2025
Q3
$739K Buy
7,574
+691
+10% +$71.6K 0.03% 430
2025
Q2
$739K Buy
6,883
+47
+0.7% +$4.76K 0.03% 417
2025
Q1
$690K Buy
6,836
+296
+5% +$29.8K 0.03% 385
2024
Q4
$584K Sell
6,540
-333
-5% -$29.3K 0.03% 420
2024
Q3
$576K Sell
6,873
-199
-3% -$15.7K 0.03% 435
2024
Q2
$545K Sell
7,072
-218
-3% -$16K 0.03% 422
2024
Q1
$499K Sell
7,290
-85
-1% -$5.46K 0.03% 466
2023
Q4
$426K Sell
7,375
-824
-10% -$44K 0.02% 476
2023
Q3
$433K Sell
8,199
-795
-9% -$41.7K 0.03% 459
2023
Q2
$486K Sell
8,994
-300
-3% -$15.7K 0.03% 441
2023
Q1
$465K Buy
9,294
+433
+5% +$20.4K 0.03% 450
2022
Q4
$410K Buy
8,861
+424
+5% +$18.4K 0.03% 455
2022
Q3
$327K Buy
8,437
+2,195
+35% +$88.1K 0.02% 482
2022
Q2
$233K Buy
+6,242
New +$254K 0.02% 586

Other funds holding BSX

Integrated Advisors Network's BSX Position: Q3 2026 in Review

Integrated Advisors Network increased its Boston Scientific (BSX) stake by 256% in Q3 2026, buying an estimated $807K and bringing the position to 24,243 shares worth $1.06M. The position accounts for 0.05% of the portfolio, ranked #311.

Integrated Advisors Network first reported a position in BSX in Q2 2022 and has held it in 18 quarters since. 922 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Integrated Advisors Network held 24,243 shares of Boston Scientific worth $1.06M as of Q3 2026.
  • Integrated Advisors Network bought 17,437 Boston Scientific shares in Q3 2026, an estimated $807K.
  • Boston Scientific made up 0.05% of Integrated Advisors Network's portfolio in Q3 2026, its #311 holding.
  • Integrated Advisors Network first reported a position in Boston Scientific in Q2 2022 and has held it in 18 quarters since.
  • 922 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Integrated Advisors Network's 13F filing for Q3 2026, filed 20 Oct 2026.